Clinical trial

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

NCT01050504

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2009-08-01

PhaseN/A

Study timeline

Study start (unknown)2009-08-01Date precision: month

Registry last updated2026-08-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Localized Renal Pelvis and Ureter Urothelial Carcinomaunresolved

Malignant Solid Neoplasmunresolved

Metastatic Malignant Neoplasm in the Boneunresolved

Metastatic Malignant Neoplasm in the Soft Tissuesunresolved

Metastatic Renal Pelvis and Ureter Urothelial Carcinomaunresolved

Recurrent Bladder Carcinomaunresolved

Recurrent Prostate Carcinomaunresolved

Recurrent Renal Pelvis and Ureter Urothelial Carcinomaunresolved

Stage IV Bladder Cancer AJCC v7unresolved

Stage IV Bladder Urothelial Carcinoma AJCC v7unresolved

Stage IV Prostate Cancer AJCC v7unresolved

Interventions

Cytology Specimen Collection ProcedureOTHER

Laboratory Biomarker AnalysisOTHER

Sponsors & collaborators

University of Washingtonlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01050504 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.